Φορτώνει......
Bortezomib treatment for severe refractory anti‐NMDA receptor encephalitis
OBJECTIVE: To evaluate the therapeutic potential of bortezomib, a proteasome inhibitor that target plasma cells, in order to revive stalled recovery in patients with anti‐N‐methyl‐d‐aspartate (NMDA) receptor encephalitis who remain bedridden even after aggressive immunotherapy. METHODS: We consecuti...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ann Clin Transl Neurol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5945964/ https://ncbi.nlm.nih.gov/pubmed/29761122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.557 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|